ebola
viru
ebov
entri
requir
virion
surfaceassoci
glycoprotein
gp
compos
trimer
heterodim
subunit
contain
two
heavili
glycosyl
domain
glycan
cap
mucinlik
domain
mld
glycan
cap
contain
nlink
glycan
wherea
mld
contain
nand
olink
glycan
sitedirect
mutagenesi
perform
ebov
systemat
disrupt
nlink
glycan
site
gain
understand
role
gp
structur
function
nglycosyl
site
ebov
could
remov
without
compromis
express
gp
loss
glycosyl
site
significantli
enhanc
pseudovirion
transduct
vero
cell
correl
increas
proteas
sensit
interestingli
expos
receptorbind
domain
rbd
remov
glycan
shield
allow
interact
endosom
receptor
indic
glycan
capmld
domain
mask
rbd
residu
requir
bind
effect
loss
nlink
glycan
ca
depend
ctype
lectin
clec
depend
transduct
complex
effect
uniqu
clec
test
surprisingli
ebov
entri
murin
periton
macrophag
independ
nglycan
suggest
nglycan
interact
requir
entri
import
primari
cell
final
remov
nglycan
outsid
mld
enhanc
antiserum
antibodi
sensit
total
result
provid
evid
conserv
nlink
glycan
ebov
core
protect
gp
antibodi
neutral
despit
neg
impact
glycan
viral
entri
effici
import
filoviru
outbreak
occur
sporad
throughout
central
africa
caus
high
fatal
rate
among
gener
public
health
care
worker
unpredict
hemorrhag
fever
outbreak
caus
multipl
speci
ebola
virus
well
marburg
viru
filoviru
vaccin
therapeut
develop
licens
product
sole
viral
envelop
glycoprotein
princip
immunogen
target
contain
heavi
shield
glycan
surround
conserv
receptorbind
domain
find
disrupt
shield
target
mutagenesi
lead
increas
cell
entri
proteas
sensit
antiserumantibodi
sensit
suffici
allow
virion
bind
intracellular
receptor
therefor
studi
provid
evid
filovirus
maintain
glycoprotein
glycosyl
protect
proteas
antibodi
neutral
expens
effici
entri
result
unveil
interest
insight
uniqu
entri
process
filovirus
potenti
immun
evas
tactic
viru
ing
diversif
region
protein
contrast
glycan
cap
mld
extens
sequenc
divers
differ
ebola
viru
speci
name
suggest
glycan
cap
mld
highli
glycosyl
result
major
protein
mask
glycan
fig
glycan
cap
contain
nlink
glycan
site
ng
despit
gener
poor
sequenc
conserv
within
glycan
cap
site
well
conserv
among
ebola
virus
suggest
function
signific
fig
contrast
glycan
cap
glycosyl
event
found
mld
highli
variabl
differ
virus
includ
nand
olink
glycan
despit
extens
glycosyl
mld
remain
highli
target
neutral
antibodi
sever
role
attribut
glycan
attach
viral
glycoprotein
glycan
serv
ligand
ca
depend
ctype
lectin
clec
facilit
viral
attach
intern
varieti
cell
type
addit
glycan
promot
protein
foldingst
virion
incorpor
gp
demonstr
studi
newcastl
diseas
viru
lassa
viru
case
nipah
viru
gf
protein
glycosyl
help
protein
express
also
decreas
membran
fusion
effici
therebi
control
prematur
fusion
event
furthermor
glycan
human
immunodefici
viru
hiv
nipah
viru
gf
hepat
c
viru
influenza
viru
hemagglutinin
ha
protect
virion
antibodymedi
neutral
despit
high
degre
glycosyl
found
filoviru
gp
import
nlink
glycan
ebov
structur
function
protein
well
studi
assess
structur
function
import
nlink
glycan
ebov
determin
role
nglycan
ebov
gpdepend
entri
librari
individu
combinatori
mutat
made
disrupt
nlink
glycan
site
ng
nxst
sequon
within
subunit
gener
ng
mutat
gp
mlddelet
gp
detail
mutat
see
tabl
supplement
materi
ng
mutant
express
cell
pseudotyp
onto
express
enhanc
green
fluoresc
protein
rel
express
level
wildtyp
wt
ng
mutant
gp
determin
assess
gptovsv
matrix
ratio
present
cell
supernat
dot
blot
analysi
addit
transduct
effici
pseudovirion
assess
vero
cell
initi
studi
perform
disrupt
seven
ng
within
core
gp
reduc
level
glycosyl
mutant
gp
pseudotyp
onto
vsv
appar
immunoblot
evidenc
faster
migrat
mutant
protein
see
fig
supplement
materi
express
wt
mutant
gp
supernat
transduct
vero
cell
mediat
virion
summar
fig
notabl
remov
glycan
core
significantli
decreas
express
concomitantli
reduc
transduct
howev
glycan
site
within
core
could
remov
effect
gp
express
signific
enhanc
transduct
wt
suggest
mld
provid
stabil
allow
remov
glycan
core
fig
furthermor
mutant
gp
incorpor
purifi
virion
rate
equival
incorpor
wt
fig
sinc
complet
deglycosyl
core
domain
neg
impact
express
gp
transduct
pseudotyp
virion
systemat
combin
nlink
glycan
mutat
mld
mutant
surprisingli
abl
disrupt
ng
within
without
affect
express
fig
see
also
fig
supplement
materi
comparison
mutant
peptid
nglycosidas
f
pngase
f
treat
gp
immunoblot
analysi
confirm
mutant
lack
nlink
glycan
fig
pseudovirion
transduct
vero
cell
significantli
enhanc
gp
mutant
lack
glycan
fig
fig
shown
light
gray
rbd
shown
red
mld
structur
solv
repres
gray
sphere
pbd
id
b
linear
model
ebov
gp
disulfid
bond
indic
well
locat
nlink
glycan
mark
ys
domain
known
proteas
cleavag
site
note
sp
signal
peptid
rbd
receptorbind
domain
mld
mucinlik
domain
ifl
intern
fusion
loop
heptad
repeat
tm
transmembran
domain
c
align
predict
nlink
glycan
site
within
core
five
ebola
viru
speci
nxst
sequon
highlight
black
background
lennemann
et
al
virion
transduct
enhanc
remov
ng
within
core
core
mld
consist
find
elimin
nglycan
sole
within
mld
also
led
modest
consist
increas
transduct
suggest
ng
core
mld
decreas
transduct
total
result
indic
nlink
glycan
requir
entri
vero
cell
rather
decreas
effici
entri
nglycan
affect
virion
attach
vero
cell
extens
nlink
deglycosyl
gp
led
greater
transduct
sought
identifi
step
ebov
entri
affect
loss
nlink
sugar
remov
nglycan
within
core
throughout
affect
bind
pseudovirion
cell
surfac
see
fig
top
supplement
materi
bind
virion
test
decreas
similar
level
reduct
presenc
calcium
chelat
egta
fig
middl
find
unexpect
sinc
ebov
entri
vero
cell
shown
mediat
phosphatidylserin
receptor
bind
virionassoci
phosphatidylserin
calciumdepend
manner
remov
nglycan
impart
catb
independ
increas
proteas
sensit
endosom
process
ebov
gp
cathepsin
b
catb
import
step
ebov
entri
result
remov
mld
glycan
cap
expos
rbd
addit
shown
disrupt
ng
mutat
lead
catb
independ
absenc
mld
inclus
similar
mutat
glycoprotein
mutant
consist
led
enhanc
transduct
assess
whether
increas
transduct
mutant
correl
increas
catb
independ
pseudovirion
entri
mediat
gp
mutant
contain
fulli
deglycosyl
glycan
cap
mutant
contain
mld
fulli
deglycosyl
nlink
glycan
abrog
treat
vero
cell
catb
inhibitor
profoundli
block
catb
activ
fig
data
indic
gp
depend
upon
catb
process
subsequ
transduct
step
fig
vsv
pseudotyp
nativ
glycoprotein
vsvg
serv
control
studi
complet
resist
drug
anticip
mutant
mutat
absenc
mld
significantli
less
sensit
fig
howev
observ
complet
catb
independ
previous
report
possibl
due
val
rather
ala
substitut
site
assess
mutant
context
gp
also
demonstr
partial
independ
catb
independ
similar
mutant
remov
nlink
glycan
enhanc
catb
independ
slightli
observ
trend
enhanc
transduct
increas
elimin
nlink
glycan
robust
trend
catb
independ
mutant
glycosyl
known
protect
proteas
determin
whether
remov
glycan
increas
proteas
sensit
gp
previou
work
shown
treatment
gml
thermolysin
thl
result
increas
gpmediat
transduct
associ
complet
remov
glycan
cap
mld
initi
assess
thl
sensit
evalu
transduct
effici
gp
follow
treatment
increas
concentr
thl
high
concentr
gml
dramat
sensit
low
concentr
thl
gp
provid
evid
deglycosyl
gp
readili
proteolyt
process
fig
given
result
panel
ng
mutant
evalu
relationship
entri
sensit
deglycosyl
gp
low
concentr
gml
proteas
fig
correl
number
mutat
thl
sensit
observ
result
indic
remov
glycan
core
greater
effect
proteas
sensit
possibl
due
larg
number
oglycan
still
present
mld
howev
show
greatest
proteas
sensit
suggest
addit
effect
mutat
combin
find
indic
nglycan
glycan
cap
lesser
extent
mld
control
effici
proteolyt
process
therebi
regul
subsequ
step
entri
bind
endosom
receptor
remov
glycan
shield
rbd
allow
bind
enzymat
remov
glycan
cap
mld
allow
interact
gp
endosom
receptor
consequ
postul
expos
rbd
disrupt
ng
within
core
mld
might
enhanc
bind
gp
bind
assay
solubl
form
second
lumin
domain
c
loop
directli
interact
residu
rbd
ebov
gp
use
bind
vsv
pseudovirion
treatment
gp
thl
commonli
use
mimic
gp
cleavag
catbl
remov
mld
glycan
cap
result
bind
c
loop
wide
rang
concentr
fig
howev
exposur
rbd
deglycosyl
lead
bind
c
loop
background
level
indic
loss
nlink
glycan
abrog
need
endosom
proteolysi
requir
receptor
interact
result
suggest
nglycan
gp
may
interfer
abil
rbd
interact
endosom
receptor
glycan
interfer
sole
explan
inabl
gp
bind
domainspecif
nlink
deglycosyl
alter
ctype
lectin
util
clec
mediat
gpdepend
entri
express
wide
varieti
ebov
target
cell
type
includ
macrophag
dendrit
cell
hepat
cell
bind
specif
glycan
moieti
better
understand
role
ebov
nlink
glycan
clecdepend
tropism
determin
receptor
util
mutant
lack
nlink
glycan
core
mld
construct
express
myctag
clec
transfect
poorli
permiss
cell
enhanc
express
ectodomain
clec
dcsign
human
mgl
hmgl
fuse
transmembran
cytoplasm
domain
lsign
result
construct
l
dcsign
l
hmgl
respect
construct
express
well
transfect
cell
fig
experi
transfect
plasmid
serv
transduct
control
sinc
entri
endosom
gp
independ
independ
gp
glycosyl
statu
consist
entri
pseudovirion
similarli
enhanc
transfect
fig
five
clec
enhanc
transduct
wt
gp
impact
loss
nglycan
transduct
vari
depend
clec
examin
fig
f
entri
mediat
lsign
l
dcsign
lsectin
highli
depend
nglycan
present
throughout
howev
lsectindepend
entri
less
depend
nglycan
present
core
fig
asialoglycoprotein
receptor
asgpri
mediat
entri
complet
independ
nglycan
core
loss
ng
mld
result
trend
decreas
transduct
achiev
statist
signific
fig
furthermor
clec
abl
mediat
entri
independ
nglycan
nlink
deglycosyl
minim
impact
gpmediat
entri
cell
express
l
hmgl
fig
result
obtain
asgpri
l
hmgl
consist
previou
report
indic
ligand
clec
present
olink
glycan
present
mld
potenti
nlink
glycan
clecexpress
cell
also
use
evalu
impact
nlink
glycan
mld
delet
mutant
studi
compar
transduct
mutant
poorli
express
result
low
level
transduct
compar
transduct
see
fig
supplement
materi
level
transduct
level
observ
gp
suffici
allow
transduct
studi
perform
fig
five
clec
enhanc
transduct
increas
entri
fig
f
case
loss
five
nlink
glycan
glycan
cap
result
decreas
transduct
reduct
modest
transduct
mediat
l
dcsign
asgpri
l
hmgl
better
transduct
cell
express
l
dcsign
asgpri
l
hmgl
result
interact
mld
glycan
enhanc
must
due
either
two
remain
intact
nglycan
core
two
nglycan
addit
differ
transduct
observ
lsign
l
dcsign
indic
clec
differ
ligand
specif
despit
bind
highmannos
oligosaccharid
nlink
glycan
requir
entri
macrophag
macrophag
major
earli
target
filoviru
infect
other
suggest
clec
may
import
entri
cell
previou
work
shown
murin
mgl
murin
homolog
dcsign
express
periton
macrophag
use
extens
deglycosyl
mutant
determin
role
nlink
olink
glycan
entri
cell
sinc
vsv
highli
sensit
type
interferon
respons
resid
periton
cell
isol
ifnar
mice
studi
addit
mice
lack
elimin
possibl
entri
epitheli
cell
may
contamin
prepar
cell
treat
day
murin
macrophag
colonystimul
factor
mcsf
phenotyp
determin
prior
use
eightyf
percent
adher
cell
periton
caviti
indic
matur
macrophag
see
fig
supplement
materi
cell
highli
permiss
vsv
pseudotyp
gp
fig
entri
mediat
entri
mediat
wt
consist
vero
cell
data
clec
util
data
furthermor
macrophag
support
entri
mediat
mutat
although
decreas
compar
result
wt
find
demonstr
neither
oor
nlink
glycan
absolut
requir
entri
periton
macrophag
remov
nlink
glycan
enhanc
antiserum
sensit
studi
indic
deglycosyl
ebov
mutant
express
wt
level
provid
highest
level
transduct
vero
cell
periton
macrophag
nonetheless
conserv
glycan
site
particularli
core
sequenc
across
speci
suggest
posit
select
site
occur
therefor
deglycosyl
ebov
gp
evalu
sensit
antiserum
neutral
sinc
deglycosyl
may
increas
exposur
potenti
ebov
gp
epitop
purifi
antiebov
igg
convalesc
cynomolgu
macaqu
vaccin
prior
challeng
ebola
viru
gift
john
dye
usamriid
incub
vsv
pseudovirion
normal
amount
matrix
protein
littl
enhanc
antiserum
sensit
observ
mutant
lack
three
glycan
gp
core
howev
remov
six
glycan
glycan
cap
increas
neutral
sensit
fig
c
contrast
vsv
pseudotyp
marburg
viru
gp
neutral
antiebov
igg
complet
deglycosyl
core
led
increas
antiserum
sensit
fig
c
sinc
mld
major
target
neutral
antibodi
anticip
remov
nglycan
domain
would
enhanc
antiebov
igg
sensit
surprisingli
sensit
neutral
wt
gp
fig
indic
ng
mld
littl
posit
neg
effect
neutral
pool
antiebov
igg
consist
remov
nlink
glycan
enhanc
antibodi
neutral
beyond
observ
deglycosyl
core
found
similar
less
pronounc
neutral
sensit
pool
sera
collect
mice
surviv
challeng
mouseadapt
ebov
see
fig
supplement
materi
ebov
highli
glycosyl
yet
limit
studi
investig
role
sugar
chain
gp
function
date
report
determin
effect
remov
nlink
glycan
present
ebov
subunit
examin
impact
protein
expressionst
viral
entri
antiserum
antibodi
sensit
surprisingli
elimin
nlink
glycan
effect
express
level
gp
suggest
presenc
mld
nlink
glycan
attach
critic
gp
fold
howev
futur
studi
test
deglycosyl
gp
context
recombin
filovirus
verifi
find
warrant
loss
ng
significantli
decreas
util
four
five
ctype
lectin
known
use
ebov
gp
entri
enhanc
ebov
transduct
vero
cell
periton
macrophag
enhanc
level
transduct
associ
enhanc
sensit
thermolysin
cleavag
deglycosyl
allevi
need
proteolysi
prior
bind
final
loss
highli
conserv
glycan
core
increas
viru
sensit
antibodi
neutral
therefor
propos
strong
conserv
individu
glycosyl
site
core
across
ebola
viru
genu
result
least
part
select
pressur
protect
viru
immun
respons
despit
fact
site
collect
neg
impact
gpdepend
entri
model
nlink
glycan
onto
structur
suggest
highli
conserv
rbd
ebola
virus
effect
mask
protect
glycan
cap
glycan
attach
wellconserv
ng
like
protect
rbd
select
immun
pressur
previous
propos
howev
provid
first
experiment
evid
support
hypothesi
result
suggest
neutral
epitop
core
normal
mask
nglycan
surprisingli
remov
nglycan
mld
highli
target
neutral
antibodi
affect
antiserum
sensit
neutral
epitop
within
mld
appear
affect
loss
nlink
glycan
may
obstruct
larg
number
oglycan
attach
mld
altern
neutral
epitop
within
mld
may
target
olink
glycan
sequon
sinc
filoviru
hemorrhag
fever
acut
often
lethal
infect
primat
like
antibodydriven
posit
select
ng
surround
conserv
region
occur
nonprim
reservoir
bat
thu
import
understand
filoviru
infect
persist
bat
popul
role
clec
ebov
gpdepend
entri
firmli
establish
other
shown
first
time
remov
nglycan
either
glycan
cap
mld
dramat
decreas
util
dcsign
lsign
lsectin
surprisingli
clec
enhanc
transduct
mediat
despit
form
protein
share
exactli
pattern
ng
anoth
surpris
find
hmgl
util
larg
unaffect
loss
nglycan
provid
indirect
evid
hmgldepend
ebov
transduct
strongli
depend
olink
glycan
gp
howev
despit
appar
util
olink
glycan
hmgl
transduct
mediat
greatli
enhanc
express
clec
combin
two
set
result
suggest
delet
mld
alter
speci
glycan
present
conclus
consist
previou
work
show
glycosyl
differ
exist
gp
small
solubl
form
gp
sgp
share
ng
glycan
process
found
sgp
indic
higher
percentag
galactos
residu
lower
percentag
highmannos
glycan
sinc
type
glycan
present
protein
larg
depend
environ
protein
produc
possibl
cytotox
associ
overexpress
gp
larg
number
oglycan
present
chang
glycosyl
machineri
ergolgi
previou
work
shown
macrophag
import
cellular
target
earli
day
filoviru
infect
effect
transduct
murin
periton
macrophag
nglycandefici
pseudovirion
along
find
hmgldepend
enhanc
transduct
rel
independ
presenc
nglycan
support
idea
propos
other
ebov
entri
macrophag
may
mediat
clec
howev
addit
mechan
ebov
entri
macrophag
also
like
import
particularli
light
find
pseudovirion
better
transduct
macrophag
gp
yet
transduc
hmglexpress
cell
transduct
level
wt
other
identifi
tim
famili
member
mediat
viru
uptak
cell
interact
phosphatidylserin
surfac
virion
possibl
uptak
mechan
import
ebov
entri
macrophag
futur
studi
need
explor
role
phosphatidylserin
receptor
vivo
filoviru
infect
find
deglycosyl
gp
pseudovirion
enhanc
transduct
vero
cell
periton
macrophag
provid
evid
nglycan
decreas
effici
entri
process
remov
glycan
mask
rbd
enhanc
proteolyt
process
gp
result
abil
unprocess
ebov
gp
bind
c
loop
consist
earlier
studi
demonstr
remov
mld
unmask
rbd
interact
result
suggest
residu
critic
bind
mask
glycan
capmld
polypeptid
rather
conceal
heavi
glycan
shield
thu
like
increas
sensit
deglycosyl
mutant
proteolyt
process
result
effici
transit
endosom
compart
lead
greater
transduct
effici
studi
found
proteas
sensit
catb
depend
independ
control
within
instanc
retain
glycosyl
site
complet
depend
catb
enhanc
thermolysin
sensit
contrast
mutant
found
partial
catb
independ
sensit
thermolysin
wt
gp
previous
hypothes
mutat
residu
elimin
nglycan
allow
endosom
proteas
catb
process
gp
within
endosom
extrapol
studi
hypothes
systemat
deglycosyl
would
yield
ebov
gp
progress
catb
independ
howev
case
extens
deglycosyl
beyond
loss
glycan
sequon
allevi
depend
catb
increas
thermolysin
sensit
addit
mutant
mutat
shown
display
differ
proteas
sensit
suggest
glycan
factor
determin
catb
depend
previou
work
shown
cellular
receptor
influenc
intracellular
traffick
endosom
fate
virus
ebov
entri
requir
specif
intracellular
compart
requir
catb
hop
complex
howev
similar
catbindepend
ebov
mutant
filovirus
requir
catb
cleavag
entri
therefor
deglycosyl
mutant
distinct
proteas
depend
sensit
profil
may
use
character
endosom
compart
allow
effici
entri
filovirus
pseudovirion
matrix
glycoprotein
quantit
equal
volum
cell
supernat
contain
pseudovirion
three
independ
stock
lyse
nativ
lysi
buffer
phosphatebuff
salin
pb
pass
dot
blot
apparatu
onto
nitrocellulos
whatman
well
wash
pb
block
pb
nonfat
milk
h
dot
blot
incub
mous
antivsv
matrix
monoclon
antibodi
mab
gift
dougla
lyle
human
antiebov
gp
mab
gift
erica
saphir
denni
burton
dilut
pb
nonfat
milk
overnight
use
separ
irdyeconjug
secondari
antibodi
ab
licor
direct
toward
primari
ab
abl
detect
vsv
matrix
protein
ebov
within
singl
well
sampl
signal
visual
quantifi
use
odyssey
imag
station
imag
studio
softwar
licor
shown
sensit
quantit
enhanc
chemiluminesc
thermolysin
sensit
assay
vsv
pseudovirion
normal
gp
express
incub
gml
serial
dilut
start
gml
singl
concentr
gml
thermolysin
thl
min
reaction
mixtur
immedi
place
ice
dilut
growth
medium
contain
phosphoramidon
sigma
thl
inhibitor
thltreat
pseudovirion
evalu
vero
cell
transduct
gfpposit
cell
analyz
flow
cytometri
antibodyantiserum
neutral
assay
serial
dilut
fraction
igg
pool
convalesc
vaccin
cynomolgu
macaqu
challeng
ebov
gift
john
dye
usamriid
pool
convalesc
sera
mice
challeng
mouseadapt
ebov
gift
gene
oling
usamriid
incub
min
pseudotyp
vsv
bear
glycoprotein
studi
normal
amount
matrix
protein
mixtur
dilut
growth
medium
ad
vero
cell
plate
format
gfpposit
cell
enumer
flow
cytometri
rel
antiserum
sensit
calcul
reciproc
infect
concentr
ic
valu
determin
graphpad
prism
supplement
materi
articl
may
found
http
mbioasmorg
tabl
pdf
file
mb
figur
pdf
file
mb
figur
pdf
file
mb
figur
pdf
file
mb
figur
pdf
file
mb
figur
pdf
file
mb
figur
pdf
file
mb
figur
pdf
file
mb
figur
pdf
file
mb
text
doc
file
mb
